TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
PCI Biotech Holding ASA
Closing information (x1000 EUR)
Closing information | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Turnover | 952 | 956 | 1,042 |
Financial expenses | 272 | 15 | 9 |
Earnings before taxes | -8,998 | -3,468 | -4,354 |
Total assets | 28,596 | 35,600 | 5,938 |
Current assets | 27,959 | 35,598 | 5,936 |
Current liabilities | 2,497 | 1,694 | 1,482 |
Equity capital | 25,838 | 33,894 | 4,252 |
- share capital | 11,335 | 11,116 | 7,618 |
Employees (average) | 0 | ||
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Solvency | 90.4% | 95.2% | 71.6% |
Turnover per employee | |||
Profit as a percentage of turnover | -945.2% | -362.8% | -417.9% |
Return on assets (ROA) | -30.5% | -9.7% | -73.2% |
Current ratio | 1119.7% | 2101.4% | 400.5% |
Return on equity (ROE) | -34.8% | -10.2% | -102.4% |
Change turnover | -20 | -66 | -23 |
Change turnover % | -2% | -6% | -2% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.